PI
ELV icon

Placemark Investments’s Elevance Health ELV Stock Holding History

Placemark Investments’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-22,665
Closed -$2.71M – 1635
2014
Q3 		$2.71M Buy
22,665
+11,752
+108% +$1.35M 0.05% 443
2014
Q2 		$1.18M Buy
10,913
+813
+8% +$83.8K 0.02% 799
2014
Q1 		$1M Sell
10,100
-4,267
-30% -$386K 0.02% 820
2013
Q4 		$1.32M Sell
14,367
-1,816
-11% -$161K 0.02% 737
2013
Q3 		$1.35M Sell
16,183
-2,138
-12% -$183K 0.03% 664
2013
Q2 		$1.5M Buy
+18,321
New +$1.37M 0.03% 593

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Placemark Investments's ELV Position: Q4 2014 in Review

Placemark Investments sold out of Elevance Health (ELV) in Q4 2014, closing a stake of 22,665 shares — an estimated $2.71M sold.

Placemark Investments first reported a position in ELV in Q2 2013 and held it in 6 quarters. The position peaked at $2.71M in Q3 2014. 720 funds tracked by Wall St. Rank hold ELV as of Q4 2014.

  • Placemark Investments reported no remaining Elevance Health position as of Q4 2014 after selling out during the quarter.
  • Placemark Investments sold 22,665 Elevance Health shares in Q4 2014, an estimated $2.71M.
  • Placemark Investments first reported a position in Elevance Health in Q2 2013 and held it in 6 quarters.
  • Placemark Investments's Elevance Health position peaked at $2.71M in Q3 2014.
  • 720 funds tracked by Wall St. Rank held Elevance Health as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.